Effects of sildenafil on the fetal growth of guinea pigs and their ability to survive induced intrapartum asphyxia

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 1, 2008, Pages 127.e1-127.e6

  Sánchez Aparicio, Pedro ^a   Mota Rojas, Daniel ^b   Nava Ocampo, Alejandro A ^c   Trujillo Ortega, Maria Elena ^a   Alfaro Rodríguez, Alfonso ^d   Arch, Emilio ^d   Alonso Spilsbury, María ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Institute de Mathematicas   (Mexico)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

Author keywords

fetal body weight; fetal organ maturity; fetal structures; guinea pigs; preclinical drug evaluations

Indexed keywords

PLACEBO; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; BODY WEIGHT; CARBON DIOXIDE TENSION; CONTROLLED STUDY; DELIVERY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FETUS; FETUS GROWTH; FETUS HYPOXIA; FETUS WEIGHT; GESTATIONAL AGE; GUINEA PIG; LOW DRUG DOSE; NEWBORN; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTECTION; RANDOMIZATION; SURVIVAL; UMBILICAL CORD;

EID: 37449034598     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.06.068     Document Type: Article

References (29)

1. Ballard S.A., Gingell C.J., Tang K., Turner L.A., Price M.E., and Naylor A.M. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159 (1998) 2164-2171
2. Chuang A.T., Strauss J.D., Murphy R.A., and Steers W.D. Sildenafil, a type-5 cGMP phsphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 160 (1998) 257-261
3. Michelakis E., Tymchak W., Lien D., Webster L., Hashimoto K., and Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 105 (2002) 2398-2403
4. Shekerdemian L.S., Ravn H.B., and Penny D.J. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 165 (2002) 1098-1102
5. Dukarm R.C., Russell J.A., Morin III F.C., Perry B.J., and Steinhorn R.H. The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation. Am J Respir Crit Care Med 160 (1999) 858-865
6. Larrue B., Jaillard S., Lorthioir M., et al. Pulmonary vascular effects of sildenafil on the development of chronic pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 288 (2005) 1193-1200
7. Belik J. Sildenafil administration during pregnancy increases fetal rat weight gain. FASEB J 19 Part 2 Suppl (2005) A1248
8. Refuerzo J.S., Sokol R.J., Aranda J.V., et al. Sildenafil citrate and fetal outcome in pregnant rats. Fetal Diagn Ther 21 (2006) 259-263
9. Lacassie H.J., Germain A.M., Valdes G., Fernandez M.S., Allamand F., and Lopez H. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 103 (2004) 1118-1120
10. Kinsella J.P., and Abman S.H. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 126 (1995) 853-864
11. Sebkhi A., Strange J.W., Phillips S.C., Wharton J., and Wilkins M.R. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation 107 (2003) 3230-3235
12. Garg N., Sharma M.K., and Sinha N. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J 151 (2006) 851.e1-5
13. Ruiz M.J., Escribano P., Delgado J.F., et al. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience. J Heart Lung Transplant 25 (2006) 1353-1357
14. Galie N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
15. Karatza A.A., Bush A., and Magee A.G. Safety and efficacy of sildenafil therapy in children with pulmonary hypertension. Int J Cardiol 100 (2005) 267-273
16. Sosenko I.R., and Frank L. Lung development in the fetal guinea pig: surfactant, morphology, and premature viability. Pediatr Res 21 (1987) 427-431
17. Maritz G.S., Morley C.J., and Harding R. Early developmental origins of impaired lung structure and function. Early Hum Dev 81 (2005) 763-771
18. Detmer A., Gu W., and Carter A.M. The blood supply to the heart and brain in the growth retarded guinea pig fetus. J Dev Physiol 15 (1991) 153-160
19. Jansson T., Cetin I., Powell T.L., et al. Placental transport and metabolism in fetal overgrowth: a workshop report. Placenta 27 Suppl A (2006) S109-S113
20. Zoma W.D., Baker R.S., Friedman A., and Clark K.E. Sildenafil citrate (Viagra) increases uterine blood flow and potentiates estrogen-induced vasodilation (A814). J Soc Gyecol Invest 8 Suppl (2001) 286A
21. Evain-Brion D., Alsat E., Igout A., Frankenne F., and Hennen G. Placental growth hormone variant: assay and clinical aspects. Acta Paediatr Suppl 399 (1994) 49-52
22. McIntyre H.D., Serek R., Crane D.I., et al. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J Clin Endocrinol Metab 85 (2000) 1143-1150
23. Chellakooty M., Vangsgaard K., Larsen T., et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J Clin Endocrinol Metab 89 (2004) 384-391
24. Trujillo-Ortega M.E., Mota-Rojas D., Hernandez-Gonzalez R., et al. Obstetric and neonatal outcomes to recombinant porcine somatotropin administered in the last third of pregnancy to primiparous sows. J Endocrinol 189 (2006) 575-582
25. Barker D.J., Osmond C., Golding J., Kuh D., and Wadsworth M.E. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298 (1989) 564-567
26. Hjalgrim L.L., Westergaard T., Rostgaard K., et al. Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiological studies. Am J Epidemiol 158 (2003) 724-735
27. Aerts L., and van Assche F.A. Intra-uterine transmission of disease. Placenta 24 (2003) 905-911
28. Togari H., Sobajima H., and Suzuki S. Oxygen and reduced umbilical blood flow trigger the first breath of human neonates. Acta Paediatr Jpn 34 (1992) 660-662
29. Abbott D., Comby P., Charuel C., et al. Preclinical safety profile of sildenafil. Int J Impot Res 16 (2004) 498-504